1.
Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma.
Emerg Infect Dis
; 27(11): 2973-2975, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1551460
ABSTRACT
A young man with smoldering multiple myeloma died of hypotensive shock 2.5 days after severe acute respiratory syndrome coronavirus 2 vaccination. Clinical findings suggested systemic capillary leak syndrome (SCLS); the patient had experienced a previous suspected flare episode. History of SCLS may indicate higher risk for SCLS after receiving this vaccine.
Subject(s)
COVID-19 , Capillary Leak Syndrome , Multiple Myeloma , Severe acute respiratory syndrome-related coronavirus , Capillary Leak Syndrome/chemically induced , Capillary Leak Syndrome/diagnosis , Humans , Male , Multiple Myeloma/complications , SARS-CoV-2
2.
CMAJ
; 193(43): E1673-E1677, 2021 11 01.
Article
in French
| MEDLINE | ID: covidwho-1546988
3.
CMAJ
; 193(34): E1341-E1344, 2021 08 30.
Article
in English
| MEDLINE | ID: covidwho-1435634
4.
Eur Urol
; 78(1): 9-10, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-99115
ABSTRACT
The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care.